Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 369,975	$ 300,784
Product revenue, net
Disaggregation of Revenue [Line Items]
Revenues	369,313	292,256
License and royalty revenues
Disaggregation of Revenue [Line Items]
Revenues	662	8,528
Total radiopharmaceutical oncology
Disaggregation of Revenue [Line Items]
Revenues	259,254	196,187
PYLARIFY
Disaggregation of Revenue [Line Items]
Revenues	258,870	195,470
Other radiopharmaceutical oncology
Disaggregation of Revenue [Line Items]
Revenues	384	717
Total precision diagnostics
Disaggregation of Revenue [Line Items]
Revenues	104,210	95,617
DEFINITY
Disaggregation of Revenue [Line Items]
Revenues	76,564	68,824
TechneLite
Disaggregation of Revenue [Line Items]
Revenues	21,714	20,986
Other precision diagnostics
Disaggregation of Revenue [Line Items]
Revenues	5,932	5,807
Strategic partnerships and other revenue
Disaggregation of Revenue [Line Items]
Revenues	$ 6,511	$ 8,980